Response rheumatoid arthritis life table analysis followup Eighty-six patients rheumatoid arthritis sulfasalazine years treatment end years probability treatment adverse effects first months treatment patients treatment inefficacy brief period improvement clinical relapse useful response treatment continuation rate years marked contrast pessimistic longterm evaluations second line drugs 